O Shaughnessy Asset Management LLC Grows Position in The Clorox Company (NYSE:CLX)

O Shaughnessy Asset Management LLC increased its position in The Clorox Company (NYSE:CLX) by 2.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,448 shares of the company’s stock after buying an additional 204 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in Clorox were worth $1,372,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Integral Investment Advisors Inc. raised its stake in shares of Clorox by 4.1% during the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock valued at $279,000 after acquiring an additional 67 shares during the last quarter. HCR Wealth Advisors raised its position in Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after purchasing an additional 68 shares during the last quarter. Sound View Wealth Advisors Group LLC lifted its holdings in Clorox by 6.1% in the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock worth $218,000 after buying an additional 77 shares during the period. Brooklyn Investment Group grew its position in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the last quarter. Finally, Global X Japan Co. Ltd. increased its stake in shares of Clorox by 3.0% during the fourth quarter. Global X Japan Co. Ltd. now owns 3,272 shares of the company’s stock valued at $531,000 after buying an additional 95 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

Shares of CLX stock opened at $143.76 on Friday. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company has a market capitalization of $17.71 billion, a price-to-earnings ratio of 39.28, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company’s 50-day moving average is $150.06 and its 200 day moving average is $158.40.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the business earned $2.16 EPS. Sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.39%. The ex-dividend date is Wednesday, April 23rd. Clorox’s payout ratio is currently 133.33%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Wells Fargo & Company cut their price target on shares of Clorox from $161.00 to $155.00 and set an “equal weight” rating on the stock in a report on Wednesday. Evercore ISI boosted their price target on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, DA Davidson dropped their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $159.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.